Skip to main content

Nanosphere Raises $26.9M in Public Offering

NEW YORK (GenomeWeb News) – Nanosphere today announced the closing of its public offering that raised $26.9 million in net proceeds.

The offering, announced last week, was of 12,075,000 shares of its common stock at a price of $2.40 per share, including 1,575,000 shares issued to underwriters' exercise in full of an overallotment option. Piper Jaffray was the sole book-running manager, and Roth Capital Partners was the co-manager of the offering.

Net proceeds will go toward general corporate purposes and working capital.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.